Rapid Emergence of Echinocandin Resistance during Candida kefyr Fungemia Treatment with Caspofungin

Archive ouverte

Fekkar, A. | Meyer, I. | Brossas, J. | Dannaoui, E. | Palous, M. | Uzunov, M. | Nguyen, S. | Leblond, V. | Mazier, D. | Datry, A.

Edité par CCSD ; American Society for Microbiology -

International audience. ABSTRACT Echinocandin drugs are widely used for the treatment of candidemia. Resistance is considered rare, and only a few cases of breakthrough candidiasis in patients receiving echinocandin have been reported worldwide. We report here for the first time a Candida kefyr isolate that acquired echinocandin resistance very rapidly after the initiation of caspofungin treatment for candidemia. We characterized the FKS gene mutation responsible for the resistance via the comparison of isolates sampled before and during treatment.

Consulter en ligne

Suggestions

Du même auteur

Emergence of echinocandin-resistant Candida spp. in a hospital setting: a consequence of 10 years of increasing use of antifungal therapy?

Archive ouverte | Fekkar, A. | CCSD

International audience

In Vitro Combination of Voriconazole and Miltefosine against Clinically Relevant Molds

Archive ouverte | Imbert, S. | CCSD

International audience. Invasive infections caused by filamentous fungi are a major threat for immunocompromised patients. Innate/acquired resistance to antifungal drugs might necessitate combination therapies. We a...

Discontinuation of echinocandin and azole treatments led to the disappearance of an FKS alteration but not azole resistance during clonal Candida glabrata persistent candidaemia

Archive ouverte | Imbert, S. | CCSD

International audience. To give an indication of a fitness cost conferred by FKS mutation–associated echinocandin resistance in Candida glabrata during human infection. Six C. glabrata clinical strains sequentially ...

Chargement des enrichissements...